Literature DB >> 17699519

Identification of residues important for agonist recognition and activation in GPR40.

Chi Shing Sum1, Irina G Tikhonova, Susanne Neumann, Stanislav Engel, Bruce M Raaka, Stefano Costanzi, Marvin C Gershengorn.   

Abstract

GPR40 was formerly an orphan G protein-coupled receptor whose endogenous ligands have recently been identified as free fatty acids (FFAs). The receptor, now named FFA receptor 1, has been implicated in the pathophysiology of type 2 diabetes and is a drug target because of its role in FFA-mediated enhancement of glucose-stimulated insulin release. Guided by molecular modeling, we investigated the molecular determinants contributing to binding of linoleic acid, a C18 polyunsaturated FFA, and GW9508, a synthetic small molecule agonist. Twelve residues within the putative GPR40-binding pocket including hydrophilic/positively charged, aromatic, and hydrophobic residues were identified and were subjected to site-directed mutagenesis. Our results suggest that linoleic acid and GW9508 are anchored on their carboxylate groups by Arg(183), Asn(244), and Arg(258). Moreover, His(86), Tyr(91), and His(137) may contribute to aromatic and/or hydrophobic interactions with GW9508 that are not present, or relatively weak, with linoleic acid. The anchor residues, as well as the residues Tyr(12), Tyr(91), His(137), and Leu(186), appear to be important for receptor activation also. Interestingly, His(137) and particularly His(86) may interact with GW9508 in a manner dependent on its protonation status. The greater number of putative interactions between GPR40 and GW9508 compared with linoleic acid may explain the higher potency of GW9508.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17699519     DOI: 10.1074/jbc.M705077200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

1.  FFA1-selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models.

Authors:  Masato Takeuchi; Akira Hirasawa; Takafumi Hara; Ikuo Kimura; Tatsuya Hirano; Takayoshi Suzuki; Naoki Miyata; Takeo Awaji; Masaji Ishiguro; Gozoh Tsujimoto
Journal:  Br J Pharmacol       Date:  2013-04       Impact factor: 8.739

Review 2.  Identifying ligands at orphan GPCRs: current status using structure-based approaches.

Authors:  Tony Ngo; Irina Kufareva; James Lj Coleman; Robert M Graham; Ruben Abagyan; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2016-03-05       Impact factor: 8.739

3.  Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator.

Authors:  Nicola J Smith; Richard J Ward; Leigh A Stoddart; Brian D Hudson; Evi Kostenis; Trond Ulven; Joanne C Morris; Christian Tränkle; Irina G Tikhonova; David R Adams; Graeme Milligan
Journal:  Mol Pharmacol       Date:  2011-04-15       Impact factor: 4.436

Review 4.  Seven transmembrane-spanning receptors for free fatty acids as therapeutic targets for diabetes mellitus: pharmacological, phylogenetic, and drug discovery aspects.

Authors:  Stefano Costanzi; Susanne Neumann; Marvin C Gershengorn
Journal:  J Biol Chem       Date:  2008-04-02       Impact factor: 5.157

Review 5.  Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.

Authors:  G Milligan; E Alvarez-Curto; K R Watterson; T Ulven; B D Hudson
Journal:  Br J Pharmacol       Date:  2015-02-27       Impact factor: 8.739

6.  Discovery of TAK-875: A Potent, Selective, and Orally Bioavailable GPR40 Agonist.

Authors:  Nobuyuki Negoro; Shinobu Sasaki; Satoshi Mikami; Masahiro Ito; Masami Suzuki; Yoshiyuki Tsujihata; Ryo Ito; Ayako Harada; Koji Takeuchi; Nobuhiro Suzuki; Junichi Miyazaki; Takashi Santou; Tomoyuki Odani; Naoyuki Kanzaki; Miyuki Funami; Toshimasa Tanaka; Akifumi Kogame; Shinichiro Matsunaga; Tsuneo Yasuma; Yu Momose
Journal:  ACS Med Chem Lett       Date:  2010-06-18       Impact factor: 4.345

7.  High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875.

Authors:  Ankita Srivastava; Jason Yano; Yoshihiko Hirozane; Georgia Kefala; Franz Gruswitz; Gyorgy Snell; Weston Lane; Anthony Ivetac; Kathleen Aertgeerts; Jasmine Nguyen; Andy Jennings; Kengo Okada
Journal:  Nature       Date:  2014-07-20       Impact factor: 49.962

8.  β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1.

Authors:  Arturo D Mancini; Gyslaine Bertrand; Kevin Vivot; Éric Carpentier; Caroline Tremblay; Julien Ghislain; Michel Bouvier; Vincent Poitout
Journal:  J Biol Chem       Date:  2015-07-08       Impact factor: 5.157

Review 9.  Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.

Authors:  Graeme Milligan; Leigh A Stoddart; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

10.  The action and mode of binding of thiazolidinedione ligands at free fatty acid receptor 1.

Authors:  Nicola J Smith; Leigh A Stoddart; Nicola M Devine; Laura Jenkins; Graeme Milligan
Journal:  J Biol Chem       Date:  2009-04-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.